Company Webinar

Kanabo Group Plc

("Kanabo" or the "Company")

Webinar and Q&A

Kanabo Group Plc (LSE:KNB), the pan-European medical cannabis Company focussing on the development and distribution of cannabis-derived products for medical patients and wellness CBD consumers, announces it will hold a company webinar via Vox Markets on Wednesday 23 February 2022 at 5.30pm (GMT).

Following the announcement made yesterday of the acquisition of the GP Service Limited (the "GP Service"), a UK-based private primary care telemedicine provider, Avihu Tamie, CEO of Kanabo, and Atul Devani, Executive Chairman and co-founder of the GP Service, will host a webinar to discuss the strategic acquisition.

Highlights:

·    The GP Service is an approved provider on the NHS digital framework for video and on-line consultations

·    The GP Service is able to able to electronically deliver prescriptions to a network of 4,200 pharmacies including major high street chains and independent pharmacies

·    The GP Service provides online GP video consultation services to corporate clients as an occupational health service for employers as well as pharmacies, including a major high street pharmacy chain

·    Kanabo intends to develop The GP Service platform to become one of Europe's first digitally led and legally compliant providers for Kanabo's products and wellness CBD services following regulatory approval

·    The acquisition will facilitate the rapid growth of the GP Service existing digital and telemedicine business and will establish a new and fully compliant channel to market for Kanabo's products

This webinar is open to all, subject to registration. To register and submit questions prior to the event, please use the following link:

https://voxmarkets.brand.live/c/kanabo-webinar

Those who follow Kanabo Group plc on the Vox Markets platform will automatically be invited.

For further information, please visit http://www.kanabogroup.com/ or contact the following:

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. It has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.